Max Robotics — Global Service Robot Directory + US Certification

About

D. Catell is a researcher specializing in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for breast cancer treatment. Their work has centered on pioneering the application of robotic linear accelerator technology to deliver precise, targeted radiation therapy for early-stage breast cancer patients — a technically demanding approach that represents a significant departure from conventional radiotherapy protocols. Catell's most notable contributions stem from their involvement in a multi-institutional clinical trial investigating SBRT as a viable treatment modality for early-stage breast cancer. Their publication record spans from 2015 through 2020, demonstrating a sustained commitment to longitudinal outcomes research. The 2020 paper reporting longer-term results from this trial is particularly significant, as extended follow-up data are critical for validating novel radiation delivery techniques in oncology settings. While Catell's citation counts remain modest — reflecting either an emerging career or a highly specialized niche — their research addresses a clinically meaningful question: whether robotic SBRT can offer patients a shorter, more convenient treatment course without compromising efficacy or safety. This body of work positions Catell as a contributor to the evolving landscape of precision radiation oncology for breast cancer.